36 Are Positive Margins in DCIS a True Indication of Inadequate Surgery?

Publication
Article
Miami Breast Cancer Conference® Abstracts Supplement39th Annual Miami Breast Cancer Conference® - Abstracts
Volume 36
Issue suppl 3
Pages: 23

Background/Significance

According to the American Society of Breast Surgeons’ 2017 “Consensus Guideline on Breast Cancer Lumpectomy Margins,” margin status serves as a surrogate marker of residual disease in the breast and has an impact on a patient’s risk of in-breast tumor recurrence. Margins for pure ductal carcinoma in situ (DCIS) treated with lumpectomy and radiation should be 2 mm or more. Close margins (<1 mm) at the chest wall or skin do not necessarily mandate reexcision. The use of margin status and lumpectomy reexcision rates as a measure of quality is controversial and may not reflect tumor biology.


Materials and Methods

To explore this in our academic community hospital, we identified 213 women diagnosed with DCIS who underwent lumpectomy and had margins assessed for a 2-mm standard from 2015 to 2020 in a retrospective study.

Results

Of 213 DCIS patients, 38 (17.8%) underwent breast conservation treatment and had positive margins on their initial pathology. Of these, 23 (60.5%) underwent a reexcision of margins in which the margins were able to be cleared: 20 of the 23 patients (87%) were found to have no residual disease in their second specimen and 3 (13%) required at least 2 additional surgical excisions of margins to be cleared after their initial surgeries. Ten of the 38 patients (26.3%) with positive margins following lumpectomy elected to proceed directly to mastectomy. All 10 were found to have residual disease. Five (13.2%) patients with positive margins had residual disease that was unable to be cleared despite surgical attempts. Negative margins were achieved in 23 (82.1%) of the 28 patients who elected to conserve their breasts.


Conclusions

While there is a consensus that 2-mm margins in DCIS are ideal, the technique to evaluate those margins is not uniform and the decisions for assessing and excising margins are still unclear. Almost half of patients with “positive margins” had no residual disease on reexcision, and in 13.2% of patients, we were unable to obtain satisfactory margins. Clearly, we need to improve our pathological assessment of margins as we learn more about the biology of DCIS.

Articles in this issue

15 COVID-19 Disease Course in Immunocompetent and Immunocompromised Patients  in a Breast Cancer Registry
15 COVID-19 Disease Course in Immunocompetent and Immunocompromised Patients in a Breast Cancer Registry
37 The Routine Use of Bioimpedance Spectroscopy Measurements in the Clinic as a Surrogate for Bone Mineral Content in Oncology Patients: Practical Application of the SOZO Device
37 The Routine Use of Bioimpedance Spectroscopy Measurements in the Clinic as a Surrogate for Bone Mineral Content in Oncology Patients: Practical Application of the SOZO Device
18 Psychosocial Wellbeing and Health Care Resource Utilization Among Patients With Breast Cancer During COVID-19
18 Psychosocial Wellbeing and Health Care Resource Utilization Among Patients With Breast Cancer During COVID-19
43 Early Detection of Breast Cancer–Related Lymphedema: Accuracy of Indocyanine Green Lymphography Compared With Bioimpedance Spectroscopy  and Symptoms
43 Early Detection of Breast Cancer–Related Lymphedema: Accuracy of Indocyanine Green Lymphography Compared With Bioimpedance Spectroscopy and Symptoms
3 Frequency of Germline Variants in Breast Cancer Predisposing Genes: Genetic Background of Brazilian Women With Breast Cancer
3 Frequency of Germline Variants in Breast Cancer Predisposing Genes: Genetic Background of Brazilian Women With Breast Cancer
44 Implementation of a Novel Radiopaque Filament Marker at a Single Breast Cancer Surgery Center
44 Implementation of a Novel Radiopaque Filament Marker at a Single Breast Cancer Surgery Center
39TiP The PREDICT Registry: A Prospective Registry Study to Evaluate the Effect of a Predictive Assay on Treatment Decisions in Patients withDCIS Following Breast Conserving Therapy
39TiP The PREDICT Registry: A Prospective Registry Study to Evaluate the Effect of a Predictive Assay on Treatment Decisions in Patients withDCIS Following Breast Conserving Therapy
38 Clinicopathological Risk Factors, Poorly Stratified Baseline Risk, and RT Benefit Compared to DCISionRT in Patients With Ductal Carcinoma in Situ
38 Clinicopathological Risk Factors, Poorly Stratified Baseline Risk, and RT Benefit Compared to DCISionRT in Patients With Ductal Carcinoma in Situ
28 Case Series: Imaging Appearance of Non–Breast Cancer Solid Masses in the Male Breast
28 Case Series: Imaging Appearance of Non–Breast Cancer Solid Masses in the Male Breast
20 Evaluating Number, Age, and Radiographic BIRADS of Patients Visiting Mammography Unit in Baghdad, Iraq, in 2019, 2020, and 2021: A Retrospective Study
20 Evaluating Number, Age, and Radiographic BIRADS of Patients Visiting Mammography Unit in Baghdad, Iraq, in 2019, 2020, and 2021: A Retrospective Study
5 Feasibility of WF-OCT as an Adjunct to Intraoperative Specimen X-ray for Breast Conservation Surgical Specimens
5 Feasibility of WF-OCT as an Adjunct to Intraoperative Specimen X-ray for Breast Conservation Surgical Specimens
41 A Single-Centre Report on the Upgrade Rate of Complex Sclerosing Lesions of the Breast
41 A Single-Centre Report on the Upgrade Rate of Complex Sclerosing Lesions of the Breast
45 The Informed Consent Experience for Breast Cancer Surgery and Its Association With Patient Satisfaction
45 The Informed Consent Experience for Breast Cancer Surgery and Its Association With Patient Satisfaction
29 The Effect of Personality Type on Satisfaction With Information Exchange in Breast Cancer Patients
29 The Effect of Personality Type on Satisfaction With Information Exchange in Breast Cancer Patients
36 Are Positive Margins in DCIS a True Indication of Inadequate Surgery?
36 Are Positive Margins in DCIS a True Indication of Inadequate Surgery?
Related Content